According to research, patients taking efgartigimod, a medication being tested for use in the treatment of chronic primary immune thrombocytopenia (ITP), showed a significantly greater improvement in platelet counts, which are necessary for clotting and stopping bleeding, compared to those taking a placebo.
According to a new, phase 2 clinical trial led by Dana-Farber Cancer Institute doctors, a three-medicine combination that drove chronic lymphocytic leukaemia (CLL) patients into profound remissions in a clinical study is very beneficial in patients with high-risk variants of the disease.
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.
Artificial intelligence can be used to turn a continuous glucose monitor (CGM) into a potent tool for diabetes monitoring and prevention, suggests researchers at Klick Applied Sciences.
Researchers at Klick Applied Sciences have figured out how to use artificial intelligence to turn a continuous glucose monitor (CGM) into a potent tool for diabetes monitoring and prevention.
Singapore/ Mumbai (Maharashtra) [India], December 2 (ANI/NewsVoir): More than 100,000 students from over 3,000 carefully selected schools are working together to break a world record by writing and printing more than ONE MILLION BOOKS in a single writing event.
New Orleans [US], October 24 (ANI): A study presented at the Anesthesiology 2022 annual meeting found that those who use cannabis experience higher pain after surgery than those who don't.
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
